230 Lilly, Specter Diagnostics, Bayer, Artisan, and Leo Pharma. Dr. and Silva have consultancies with Eli Lilly. Dr. Angus has partic- Artigas has received grants from Eli Lilly. Dr. Beale has disclosed ipation in DSMB, Prowess-Shock, and Eli Lilly. The remaining payment from multiple sources that were paid to his department authors have not disclosed any potential conﬂicts of interest. and institution (details on ﬁle with the editorial ofﬁce). Drs. Reihart References 1. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR (2001) Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29:1303–1310 2. Martin GS, Mannino DM, Eaton S, Moss M (2003) The epidemiology of sepsis in the United States from 1979– 2000. N Engl J Med 348:1546–1554 3. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M, Early Goal-Directed Therapy Collaborative Group (2001) Early goal directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345:1368–1377 4. Annane D, Se´bille V, Charpentier C, Bollaert PE, Franc¸ois B, Korach JM, Capellier G, Cohen Y, Azoulay E, Troche´ G, Chaumet-Riffaud P, Bellissant E (2002) Effect of treatment with low doses of hydrocortisone and ﬂudricortisone on mortality in patients with septic shock. JAMA 288:862–871 5. Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez- Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fisher CJ Jr, Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group (2001) Efﬁcacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344:699–709 6. van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R (2001) Intensive insulin therapy in critically ill patients. N Engl J Med 345:1359–1367 7. The Acute Respiratory Distress Syndrome Network (2000) Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 342:1301–1308 8. Kress JP, Pohlman AS, O’Connor MF, Hall JB (2000) Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. N Engl J Med 342:1471– 1477 9. Ely EW, Baker AM, Dunagan DP, 16. Sinuff T, Eva KW, Meade M, Dodek P, Burke HL, Smith AC, Kelly PT, Heyland D, Cook D (2007) Clinical Johnson MM, Browder RW, Bowton practice guidelines in the intensive care DL, Haponik EF (1996) Effect on the unit: a survey of Canadian clinicians’ duration of mechanical ventilation of attitudes. Can J Anaesth 54:728–736 identifying patients capable of 17. Cook DJ, Meade MO, Hand LE, breathing spontaneously. N Engl J Med McMullin JP (2002) Toward 335:1864–1869 understanding evidence uptake: 10. Bellomo R, Chapman M, Finfer S, semirecumbency for pneumonia Hickling K, Myburgh J (2000) Low- prevention. Crit Care Med 30:1472– dose dopamine in patients with early 1477 renal dysfunction: a placebo-controlled 18. Sinuff T, Kahnamoui K, Cook DJ, randomised trial. Australian and New Giacomini M (2007) Practice guidelines Zealand intensive care society as multipurpose tools: a qualitative (ANZICS) clinical trials group. Lancet study of noninvasive ventilation. Crit 356:2139–2143 Care Med 35:776–782 11. Townsend SR, Schorr C, Levy MM, 19. Sinuff T, Muscedere J, Cook D, Dodek Dellinger RP (2008) Reducing P, Heyland D (2008) Canadian Critical mortality in severe sepsis: The Care Trials Group. Ventilator- Surviving Sepsis Campaign. Clin Chest associated pneumonia: improving Med 29:721–733 outcomes through guideline 12. Dellinger RP, Carlet JM, Masur H, implementation. J Crit Care 23:118– Gerlach H, Calandra T, Cohen J, Gea- 125 Banacloche J, Keh D, Marshall JC, 20. Sinuff T, Cook D, Giacomini M, Parker MM, Ramsay G, Zimmerman Heyland D, Dodek P (2007) Facilitating JL, Vincent JL, Levy MM, Surviving clinician adherence to guidelines in the Sepsis Campaign Management intensive care unit: a multicenter, Guidelines Committee (2004) qualitative study. Crit Care Med Surviving Sepsis Campaign guidelines 35:2083–2089 for management of severe sepsis and 21. Pronovost PJ, Berenholtz SM, Needham septic shock. Crit Care Med 32:858– DM (2008) Translating evidence into 873 practice: a model for large scale 13. Dellinger RP, Levy MM, Carlet JM, knowledge translation. BMJ 337:963– Bion J, Parker MM, Jaeschke R, 965 Reinhart K, Angus DC, Brun-Buisson 22. Vandijck DM, Labeau SO, Blot SI C, Beale R, Calandra T, Dhainaut JF, (2008) Facilitating clinician adherence Gerlach H, Harvey M, Marini JJ, to guidelines in the intensive care unit. Marshall J, Ranieri M, Ramsay G, Crit Care Med 36:655 Sevransky J, Thompson BT, Townsend 23. Berwick DM (2008) The science of S, Vender JS, Zimmerman JL, Vincent improvement. JAMA 299:1182–1184 JL (2008) Surviving Sepsis Campaign: 24. Amalberti R, Auroy Y, Berwick D, international guidelines for Barach P (2005) Five system barriers to management of severe sepsis and septic achieving ultrasafe health care. Ann shock: 2008. Intensive Care Med Intern Med 142:756–764 34:17–60, erratum 34:783–785 25. Levy MM, Pronovost PJ, Dellinger RP, 14. Surviving Sepsis Campaign Townsend SR, Resar RK, Clemmer TP, implementation and the appropriate role Ramsay G (2004) Sepsis change of industry. bundles: converting guidelines into http://www.survivingsepsis.org/ meaningful change in behavior and About_the_Campaign/Documents/ clinical outcome. Crit Care Med Industry_20Fact_20Sheet__2003- 32(suppl):S595–S597 2006_2_.pdf. Accessed 5 Dec 2009 26. Resar R, Pronovost P, Haraden C, 15. Cabana MD, Rand CS, Powe NR, Wu Simmonds T, Rainey T, Nolan T (2005) AW, Wilson MH, Abboud PA, Rubin Using a bundle approach to improve HR (1999) Why don’t physicians ventilator care processes and reduce follow clinical practice guidelines? A ventilator-associated pneumonia. Jt framework for improvement. JAMA Comm J Qual Patient Saf 31:243–248 282:1458–1465